JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2006; 47:7-12, doi:10.1016/j.jacc.2005.09.068
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Falk, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Falk, E.

Pathogenesis of Atherosclerosis

Erling Falk, MD, PhD*

Department of Cardiology, Aarhus University Hospital (Skejby), Aarhus, Denmark.

Manuscript received June 16, 2005; revised manuscript received September 12, 2005, accepted September 19, 2005.

* Reprint requests and correspondence: Dr. Erling Falk, Department of Cardiology, Aarhus University Hospital (Skejby), Brendstrupgaardsvej, DK-8200 Aarhus N, Denmark. (Email: erling.falk{at}ki.au.dk).

Atherosclerosis is a multifocal, smoldering, immunoinflammatory disease of medium-sized and large arteries fuelled by lipids. Endothelial cells, leukocytes, and intimal smooth muscle cells are the major players in the development of this disease. The most devastating consequences of atherosclerosis, such as heart attack and stroke, are caused by superimposed thrombosis. Therefore, the vital question is not why atherosclerosis develops but rather why atherosclerosis, after years of indolent growth, suddenly becomes complicated with luminal thrombosis. If thrombosis-prone plaques could be detected and thrombosis averted, atherosclerosis would be a much more benign disease. Approximately 76% of all fatal coronary thrombi are precipitated by plaque rupture. Plaque rupture is a more frequent cause of coronary thrombosis in men (~80%) than in women (~60%). Ruptured plaques are characterized by a large lipid-rich core, a thin fibrous cap that contains few smooth muscle cells and many macrophages, angiogenesis, adventitial inflammation, and outward remodeling. Plaque rupture is the most common cause of coronary thrombosis. Ruptured plaques and, by inference, rupture-prone plaques have characteristic pathoanatomical features that might be useful for their detection in vivo by imaging. This article describes the pathogenesis of atherosclerosis, how it begets thrombosis, and the possibility to detect thrombosis-prone plaques and prevent heart attack.

Abbreviations and Acronyms
  HDL = high-density lipoprotein
  LDL = low-density lipoprotein
  MCP-1 = monocyte chemotactic protein-1
  NOS = nitric oxide synthase
  VCAM-1 = vascular cell adhesion molecule-1




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. C. Doran, N. Meller, and C. A. McNamara
Role of Smooth Muscle Cells in the Initiation and Early Progression of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 812 - 819.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. N. Diringer, B. E. Skolnick, S. A. Mayer, T. Steiner, S. M. Davis, N. C. Brun, and J. P. Broderick
Risk of Thromboembolic Events in Controlled Trials of rFVIIa in Spontaneous Intracerebral Hemorrhage
Stroke, March 1, 2008; 39(3): 850 - 856.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Knapp, J. E. Ramsey, S.-X. Wang, A. R. Strauch, and R. J. Kelm Jr.
Structure-Function Analysis of Mouse Pur II: CONFORMATION ALTERING MUTATIONS DISRUPT SINGLE-STRANDED DNA AND PROTEIN INTERACTIONS CRUCIAL TO SMOOTH MUSCLE {alpha}-ACTIN GENE REPRESSION
J. Biol. Chem., December 7, 2007; 282(49): 35899 - 35909.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Tello-Montoliu, F. Marin, J. Patel, V. Roldan, L. Mainar, V. Vicente, F. Sogorb, and G. Y.H. Lip
Plasma angiogenin levels in acute coronary syndromes: implications for prognosis
Eur. Heart J., December 2, 2007; 28(24): 3006 - 3011.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
N. M. Punjabi, B. A. Beamer, A. Jain, M. E. Spencer, and N. Fedarko
Elevated Levels of Neopterin in Sleep-Disordered Breathing
Chest, October 1, 2007; 132(4): 1124 - 1130.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Dalager, W. P. Paaske, I. Bayer Kristensen, J. Marsvin Laurberg, and E. Falk
Artery-Related Differences in Atherosclerosis Expression: Implications for Atherogenesis and Dynamics in Intima-Media Thickness
Stroke, October 1, 2007; 38(10): 2698 - 2705.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Falk, S. M. Schwartz, Z. S. Galis, and M. E. Rosenfeld
Putative Murine Models of Plaque Rupture
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 969 - 972.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. C. Thomas, G. B. Sala-Newby, Y. Ismail, J. L. Johnson, G. Pasterkamp, and A. C. Newby
Genomics of Foam Cells and Nonfoamy Macrophages From Rabbits Identifies Arginase-I as a Differential Regulator of Nitric Oxide Production
Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 571 - 577.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Tsimikas, M. Aikawa, F. J. Miller Jr, E. R. Miller, M. Torzewski, S. R. Lentz, C. Bergmark, D. D. Heistad, P. Libby, and J. L. Witztum
Increased Plasma Oxidized Phospholipid:Apolipoprotein B-100 Ratio With Concomitant Depletion of Oxidized Phospholipids From Atherosclerotic Lesions After Dietary Lipid-Lowering: A Potential Biomarker of Early Atherosclerosis Regression
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 175 - 181.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. E. Muller, A. Tawakol, S. Kathiresan, and J. Narula
New opportunities for identification and reduction of coronary risk treatment of vulnerable patients, arteries, and plaques.
J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C2 - C6.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.